Dr. Peter Hotez

Who is Dr. Peter Hotez?

Peter Hotez, M.D., Ph.D. is Dean of the National School of Tropical Medicine and Professor of Pediatrics and Molecular Virology & Microbiology at Baylor College of Medicine where he is also the Director of the Texas Children’s Center for Vaccine Development (CVD) and Texas Children’s Hospital Endowed Chair of Tropical Pediatrics.

Topics and Timestamps

• 01Dr. Peter Hotez discusses his work developing vaccines for neglected tropical diseases affecting the world's poorest populations
• 02The conversation covers vaccine development timelines, safety testing protocols, and why certain diseases get less funding despite massive global impact
• 03Hotez explains the difference between tropical medicine focus areas and the diseases that get mainstream attention in wealthy countries
• 04Discussion of his experience as a vaccine scientist and the challenges of public communication around vaccine safety
• 05The conversation touches on global health disparities and how pharmaceutical incentives affect which diseases get research funding
• 06Hotez shares insights about his work at Baylor College of Medicine and the Texas Children's Center for Vaccine Development
• ▶Introduction to tropical medicine and neglected diseases0:00:00
• ▶Explanation of vaccine development timelines and safety protocols0:12:30
• ▶Discussion of why certain diseases get less funding despite massive global impact0:28:45
• ▶Hotez explains the economics of pharmaceutical development and profit incentives0:45:20
• ▶Conversation about science communication and public trust in vaccines1:02:15

The Show

Joe brings on Dr. Peter Hotez, one of the world's leading vaccine researchers and tropical medicine experts, to discuss the real work that goes into vaccine development and global health. Hotez runs the vaccine development center at Texas Children's Hospital and has spent his career fighting diseases that kill millions but don't make headlines in America.

The core of the conversation revolves around how pharmaceutical companies and governments decide which diseases are worth researching. Hotez explains that tropical diseases affecting the poorest people in Africa and Asia get dramatically less funding than diseases affecting wealthy Western populations. It's not a conspiracy or malice, it's just basic economics. There's no money in curing diseases in countries where people can't afford expensive treatments. So diseases like hookworm, dengue, and leishmaniasis that affect hundreds of millions of people remain relatively neglected.

Hotez walks Joe through what actual vaccine development looks like. It's not some rushed operation. The process involves years of lab work, animal testing, clinical trials in multiple phases, and regulatory review. He explains why certain safety measures exist and what the actual risks are versus the perceived risks that circulate online. The guy has dedicated his life to this work and has genuine passion for explaining the science.

They discuss the challenges of being a public scientist, especially in an era where misinformation spreads faster than facts. Hotez touches on the frustration of doing rigorous work only to see it oversimplified or weaponized in public debates. He's clearly thought a lot about science communication and why experts sometimes fail to connect with regular people.

The episode also covers Hotez's personal journey into medicine and why he chose to focus on diseases most people have never heard of. There's a humanitarian angle here that comes through clearly. He's not trying to get rich off pharmaceuticals. He's trying to solve problems that the market has deemed unsolvable.

Best Quotes